/
CAI
$17.78-$0.54 (-2.95%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$5.2B
283M shares
52-week range
$14.19 – $42.50
13% from low
Sector
SERVICES-MEDICAL LABORATORIES
Exchange
NASDAQ
CS
Borrow rate
0.77%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-37.99
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $348.4M | $432.1M | $416.5M | $294.0M | $258.5M | $306.1M | $412.3M | $812.0M |
| Cost of revenue | $179.1M | $218.5M | $216.0M | $109.9M | $178.5M | $216.8M | $233.5M | $272.9M |
| Gross profit | $169.3M | $213.6M | $200.5M | $184.2M | $80.0M | $89.3M | $178.8M | $539.2M |
| Gross margin | 48.6% | 49.4% | 48.1% | 62.6% | 31.0% | 29.2% | 43.4% | 66.4% |
| R&D | $0 | $0 | $0 | $0 | $101.3M | $116.9M | $113.9M | $45.3M |
| Operating income | $105.7M | $148.8M | $130.3M | $139.1M | −$315.8M | −$319.6M | −$257.1M | $45.1M |
| EBITDA | $223.5M | $283.3M | $248.3M | $254.5M | −$245.9M | −$260.8M | −$183.0M | $11.4M |
| Net income | $72.1M | $78.6M | $31.0M | $27.7M | −$320.8M | −$341.4M | −$281.9M | −$538.0M |
| Net margin | 20.7% | 18.2% | 7.4% | 9.4% | -124.1% | -111.5% | -68.4% | -66.2% |
| EPS (diluted) | 3.68 | 3.97 | 1.72 | 1.55 | -1.57 | -1.82 | -2.70 | -1.90 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $1.0B | $0.13 | $0.13–$0.13 | 8 |
| 2027 | $1.2B | $0.33 | $0.18–$0.49 | 8 |
| 2028 | $1.4B | $0.55 | $0.38–$0.90 | 7 |
| 2029 | $1.6B | $0.78 | $0.74–$0.81 | 2 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Caris Life Sciences, Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
www.carislifesciences.com- Employees
- 1,846
- IPO / List date
- Jun 18, 2025
- HQ
- IRVING, TX
Held by traders on TradeandTell
No one on the platform currently holds CAI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 449,900 | $8.0M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CAI yet.
